Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.01 | 0.523 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.523 | 0.4763 |
Echinococcus granulosus | glucose 6 phosphate 1 dehydrogenase | 0.0099 | 0.5128 | 0.9611 |
Plasmodium falciparum | glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0.0108 | 0.5827 | 0.1547 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0156 | 0.9647 | 1 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.01 | 0.523 | 0.0225 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.01 | 0.523 | 0.3545 |
Trichomonas vaginalis | valacyclovir hydrolase, putative | 0.0156 | 0.9647 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0127 | 0.7329 | 0.6385 |
Echinococcus granulosus | caspase 3 | 0.0072 | 0.3008 | 0.152 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0156 | 0.9647 | 1 |
Plasmodium falciparum | lysophospholipase, putative | 0.0156 | 0.9647 | 1 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0099 | 0.51 | 0.9668 |
Mycobacterium ulcerans | glucose-6-phosphate 1-dehydrogenase | 0.0099 | 0.5128 | 0.3761 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.01 | 0.523 | 0.0225 |
Echinococcus granulosus | caspase 3 apoptosis cysteine peptidase | 0.0099 | 0.51 | 0.9505 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0108 | 0.5827 | 0.5471 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.523 | 0.4763 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0156 | 0.9647 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.261 | 0.3302 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.261 | 0.3302 |
Schistosoma mansoni | serine/threonine protein kinase | 0.01 | 0.523 | 1 |
Loa Loa (eye worm) | glucose-6-phosphate dehydrogenase | 0.0099 | 0.5128 | 0.3407 |
Echinococcus multilocularis | caspase 3 | 0.0072 | 0.3008 | 0.152 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0156 | 0.9647 | 1 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.01 | 0.523 | 0.3545 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.261 | 0.3302 |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.261 | 0.3302 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.523 | 0.4763 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0156 | 0.9647 | 1 |
Treponema pallidum | glucose-6-phosphate 1-dehydrogenase | 0.0099 | 0.5128 | 0.5 |
Plasmodium vivax | PST-A protein | 0.0156 | 0.9647 | 1 |
Leishmania major | monoglyceride lipase, putative | 0.0156 | 0.9647 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0156 | 0.9647 | 1 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.01 | 0.523 | 1 |
Trichomonas vaginalis | 6-phosphogluconolactonase, putative | 0.0108 | 0.5827 | 0.5471 |
Plasmodium falciparum | lysophospholipase, putative | 0.0156 | 0.9647 | 1 |
Giardia lamblia | Glucose-6-phosphate 1-dehydrogenase | 0.0108 | 0.5827 | 1 |
Onchocerca volvulus | 0.016 | 1 | 1 | |
Schistosoma mansoni | tar DNA-binding protein | 0.0067 | 0.261 | 0.3302 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.0099 | 0.51 | 0.9668 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0127 | 0.7329 | 0.6385 |
Plasmodium falciparum | lysophospholipase, putative | 0.0156 | 0.9647 | 1 |
Schistosoma mansoni | glucose-6-phosphate 1-dehydrogenase | 0.0099 | 0.5128 | 0.974 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0156 | 0.9647 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.523 | 0.4763 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0127 | 0.7329 | 0.6385 |
Mycobacterium tuberculosis | Possible lysophospholipase | 0.0156 | 0.9647 | 1 |
Echinococcus granulosus | caspase | 0.0099 | 0.51 | 0.9505 |
Echinococcus multilocularis | glucose 6 phosphate 1 dehydrogenase | 0.0099 | 0.5128 | 0.9611 |
Trypanosoma cruzi | monoglyceride lipase, putative | 0.0156 | 0.9647 | 1 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.0099 | 0.51 | 0.9505 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0156 | 0.9647 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.523 | 0.4763 |
Mycobacterium leprae | POSSIBLE LYSOPHOSPHOLIPASE | 0.0156 | 0.9647 | 0.5 |
Trichomonas vaginalis | glucosamine-6-phosphate isomerase, putative | 0.0108 | 0.5827 | 0.5471 |
Toxoplasma gondii | glucose-6-phosphate 1-dehydrogenase | 0.0108 | 0.5827 | 1 |
Plasmodium falciparum | esterase, putative | 0.0156 | 0.9647 | 1 |
Trichomonas vaginalis | Clan SC, family S33, methylesterase-like serine peptidase | 0.0156 | 0.9647 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0156 | 0.9647 | 1 |
Trypanosoma brucei | polo-like protein kinase | 0.01 | 0.523 | 0.0225 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.523 | 0.4763 |
Brugia malayi | glucose-6-phosphate dehydrogenase | 0.0099 | 0.5128 | 0.3407 |
Chlamydia trachomatis | glucose-6-phosphate 1-dehydrogenase | 0.0099 | 0.5128 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.01 | 0.523 | 0.4763 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.01 | 0.523 | 0.0225 |
Trypanosoma brucei | monoglyceride lipase, putative | 0.0156 | 0.9647 | 1 |
Entamoeba histolytica | hydrolase, alpha/beta fold family domain containing protein | 0.0156 | 0.9647 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.016 | 1 | 1 |
Mycobacterium ulcerans | lysophospholipase | 0.0156 | 0.9647 | 1 |
Echinococcus multilocularis | caspase | 0.0099 | 0.51 | 0.9505 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.